HIV prevalence among women attending termination of pregnancy (TOP) services
| Authors, publication year | Publication type | Geographical location | Study period | Total participants, n (TOP/delivery) | Overall HIV prevalence in TOP (%) | Prevalence of new HIV infections in TOP (%) | HIV prevalence in women delivering (%) | HIV prevalence in general population* (%) |
| Unlinked anonymous testing studies | ||||||||
| Goldberg et al, 199221 | Article | Dundee, Scotland | 1988–1990 | 6228 (1535/4693) | 0.85 | – | 0.13 | – |
| Couturier et al, 199217 | Article | Paris, France | 1990–1991 | 11 593 (2718/7261) | 0.7 | – | 0.28 | – |
| Obadia et al, 199418 | Article | France (Southeast) | 1991–1992 | 11 056 (2298/7301) | 0.56 | – | 0.22 | – |
| Remis et al, 199523 | Article | Montreal, Canada | 1989–1993 | 12 017 | – | 0.18 | – | 0.21 |
| Abeni et al, 199719 | Article | Rome, Italy | 1989–1994 | 218 357 (61 777/138 359) | 0.49 | – | 0.18 | – |
| Goldberg et al, 200034 | Article | Dundee, Scotland | 1993–1997 | 17 899 (4650/13 249) | 0.15 | – | 0.11 | – |
| Drey et al, 200524 | Article | San Francisco, USA | 2002–2003 | 1992 | 0.55 | – | – | – |
| Thornton et al, 200722 | Abstract | London, UK | 2005 | Not available | 1.01 | – | 0.44 | – |
| Carnicer-Pont et al, 201120 | Article | Catalonia, Spain | 1999–2006 | 581 593 (31 904/549 689) | 0.13 | – | 0.18 | – |
| Routine testing studies† | ||||||||
| Crowe, 200826 | Abstract | London, UK | 2003–2007 | 1618 | 0.77 | 0.45 | – | – |
| Creighton et al, 200925 | Abstract | London, UK | 2008 | 699‡ | 0.6 | – | – | – |
| Garrard et al, 201028 | Abstract | London, UK | 2008–2009 | 2831‡ | – | 0.52 | – | – |
| Rosenvinge et al, 201027 | Abstract | London, UK | 2009 | 844 | 0.56 | – | – | – |
| Creighton et al, 201231 | Letter | London, UK | 2008–2011 | 4326 | 0.82 | 0.3 | – | 0.8 |
Articles are listed in chronological order of publication.
Created by the authors.
*Measured in the same geographical region and period.
†For routine testing studies, the number of participants refers to the number of women offered HIV testing in TOP settings whether they accepted or declined testing; prevalence refers to the proportion of participants who tested positive for HIV infection out of the participants who accepted HIV testing.
‡Opt-out testing.